O-158 A randomized phase II ECOG trial of two dose levels of temsirolimus (CCI-779) in patients with extensive stage small cell lung cancer in remission after induction therapy
Pandya, K., Levy, D., Hidalgo, M., Cohen, R., Lee, M., Dancey, J., Schiller, J., Johnson, D.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)80292-2
Date:
July, 2005
File:
PDF, 144 KB
english, 2005